Fungi don’t just die when you treat them - they adapt. We’re have a competition-funded #PhD to watch them do it in 3-D in real time using #NMR. 🍄 Fully funded, 4 years at the @NorwichResearch. Please get in touch if interested! #NMRchatbiodtp.norwichresearchpark.a…
Fungi don’t just die when you treat them - they adapt. We’re have a competition-funded #PhD to watch them do it in 3-D in real time using #NMR. 🍄 Fully funded, 4 years at the @NorwichResearch. Please get in touch if interested! #NMRchatbiodtp.norwichresearchpark.a…
China has selected its first group of young researchers to receive funding for up to 15 years, in one of the longest research grants on offer to scientists globally
go.nature.com/4z4Q3pw
Curious about the evolutionary roles of carbohydrate-binding modules in amylolytic #enzymes? Are you curious about structure-function relationships in proteins? Come do a #PhD with us in a great #NMR team! #NMRChatbiodtp.norwichresearchpark.a…
Dr Matthew Wallace from @uniofeastanglia showcasing his group's work on aqueous pKa determination of water-insoluble drugs using chemical shift imaging #NMR at #JPAG 2025. #NMRChat
For over a century, the hunt for new antibiotics has focused almost exclusively on bacteria and fungi. Today, that paradigm shifts. By coupling state-of-the-art AI with the vast, largely uncharted diversity of Archaea, we open a new frontier for molecular discovery.
Our APEX model sifted through hundreds of archaeal proteomes in silico, revealing a previously hidden family of antimicrobial peptides we call “archaeasins.” Of the 80 candidates we synthesized, 93% were active against pathogenic microbes in vitro, and one—archaeasin-73—matched the in-vivo efficacy of last-resort drugs such as polymyxin B.
These results show that the marriage of deep learning and evolutionary diversity can surface potent therapeutics at digital speed, expanding the antibiotic toolbox when humanity needs it most. Archaea, once thought biologically esoteric, now stand alongside bacteria and fungi as a rich reservoir of useful molecules.
We are excited to keep discovering antibiotics at digital speed with AI.
Link to the paper @NatureMicrobiol@NaturePortfolio: nature.com/articles/s41564-0…
We are expanding our team at Utrecht University and we are looking for a Research Technician w/ interest in natural product isolation (especially lipids) for applications in drug development and pharmaceutical formulations.
Apply here:
lnkd.in/eRre9P9S#jobs#technician
A postdoctoral position, funded by the @LeverhulmeTrust for up to 36 months, is available to join my group @EdinburghChem. The project focuses on biomimetic approaches to natural product synthesis.
Deadline: 28th August 2025.
elxw.fa.em3.oraclecloud.com/…
Dr Trey Koev (@TTKoev) from the Wallace group at @uniofeastanglia giving a talk on problems with current consensus methods for testing #DrugDelivery vehicles, and novel #NMR methods of solving them. #NMRChat
Interested in a new, easy to set-up #NMR method for probing crosstalk between #cells across distances?
Check out our new paper in @an_chem on spatially encoded NMR to probe colonocyte-commensal metabolic crosstalk in a simulated #HumanGut. #NMRChatpubs.acs.org/doi/10.1021/acs…
🚨 PhD Opportunity 🚨 Would you like to join my group at @UoBChemistry? The school will support 3 exceptional applicants (typically 1st class honours or equivalent).
🗓️ Closing date: Midnight, 3 Feb 2025
🏆 Awards based on academic excellence.
📩 E-mail me for details.